Dr. Mohammed Miradi, MD

Dr. Miradi practices at Sharp Grossmont Hospital in La Mesa, California.

Dr. Miradi's NPI, 1225077654, was assigned on June 4, 2006. Dr. Miradi graduated from Tehran University of Medical Sciences School of Medicine in 1981. Dr. Miradi holds California license A53125.

Dr. Miradi's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Dr, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 740-6000.

Dr. Miradi's primary practice is Sharp Grossmont Hospital in La Mesa, California. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Miradi to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miradi practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Miradi's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Miradi's licenses on file in 8 states: California, North Carolina, New York, Iowa, Ohio, Minnesota, Kentucky and Washington.

Dmand AI lists hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Miradi treats.

CMS data shows 452 Medicare services from Dr. Miradi across 3 procedure codes in 2024, for 98 Medicare patients. Medicare paid $33,395 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Miradi in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miradi's median patient age at 62, with 25% women.

In 2024, Dr. Miradi wrote 142 Medicare Part D claims for 36 patients. 68% of them were for generic drugs. CMS names the drug for 32 of them, across 1 drug with 11 or more claims each, at $121,450 in total drug cost. In 2023, CMS named 105 claims across 5 drugs.

Dmand AI links 1 paper to Dr. Miradi. Dr. Miradi's most frequent co-authors are Catherine Diamond, MD and Mark S. Wallace, MD.

CMS Open Payments shows 1 general payment to Dr. Miradi from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $117.

Dr. Miradi graduated from Tehran University of Medical Sciences School of Medicine in 1981.

Dr. Miradi is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.